Pharmaceutical R&D-To-Sales Expenditure Ratio Declines

Research and development (R&D) spending by brand-name drug companies in Canada has dropped to its lowest level in 20 years, according to the latest annual report of the Patented Medicines Prices Review Board (PMPRB). In 2009, branded drugmakers such as

To read the full article, please choose one of the following options: